CARIS LIFE SCIENCES, INC. Share-based Payment Arrangement, Expense
CARIS LIFE SCIENCES, INC. (CAI) reported Share-based Payment Arrangement, Expense of $22.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $22.22M, a 21.47% decline year-over-year.
- CARIS LIFE SCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $15.87M, a 8.04% increase year-over-year.
- CARIS LIFE SCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $13.37M, a 168.58% increase year-over-year.
- CARIS LIFE SCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $13.65M, a 189.12% increase year-over-year.
- CARIS LIFE SCIENCES, INC. share-based payment arrangement, expense for fiscal 2025 was $70.01M, a 275.51% increase from fiscal 2024.
- CARIS LIFE SCIENCES, INC. share-based payment arrangement, expense for fiscal 2024 was $18.64M, a 22.33% increase from fiscal 2023.
- CARIS LIFE SCIENCES, INC. share-based payment arrangement, expense for fiscal 2023 was $15.24M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.22M 10-Q · filed 2026-08-05 | $38.09M 10-Q · filed 2026-08-05 | $51.46M derived: sum of 3 quarters · filed 2026-08-05 | $65.11M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $15.87M 10-Q · filed 2026-05-08 | $29.24M derived: sum of 2 quarters · filed 2026-05-08 | $42.89M derived: sum of 3 quarters · filed 2026-05-08 | $71.19M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $13.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $27.02M derived: sum of 2 quarters · filed 2026-03-03 | $55.31M derived: sum of 3 quarters · filed 2026-08-05 | $70.01M 10-K · filed 2026-03-03 |
| 2025-09-30 | $13.65M 10-Q · filed 2025-11-05 | $41.95M derived: sum of 2 quarters · filed 2026-08-05 | $56.64M 10-Q · filed 2025-11-05 | $61.62M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $28.29M 10-Q · filed 2026-08-05 | $42.98M 10-Q · filed 2026-08-05 | $47.96M derived: sum of 3 quarters · filed 2026-08-05 | $52.68M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $14.69M 10-Q · filed 2026-05-08 | $19.67M derived: sum of 2 quarters · filed 2026-05-08 | $24.39M derived: sum of 3 quarters · filed 2026-05-08 | $28.88M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $4.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $9.70M derived: sum of 2 quarters · filed 2026-03-03 | $14.19M derived: sum of 3 quarters · filed 2026-03-03 | $18.64M 10-K · filed 2026-03-03 |
| 2024-09-30 | $4.72M 10-Q · filed 2025-11-05 | $9.21M derived: sum of 2 quarters · filed 2025-11-05 | $13.67M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $4.49M 10-Q · filed 2025-08-12 | $8.94M 10-Q · filed 2025-08-12 | ||
| 2023-12-31 | $15.24M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |